Cannabis company Terra Tech Corp (OTC: TRTC) recently signed a letter of intent to merge with Golden Leaf Holdings Ltd. (OTC: GLDFF).
Under the terms of the deal, a wholly owned subsidiary of Terra Tech will merge with Golden Leaf, with the new company continuing to be a wholly owned subsidiary of Terra Tech. The transaction is all-stock, with Golden Leaf shareholders entitled to receive 0.1203 shares of Terra Tech for each share of Golden Leaf. This translates into around 22 cents per share of Golden Leaf at the current value of Terra Tech's stock.
The transaction has to be approved by regulators, as well as by Terra Tech's board and Golden Leaf's board and shareholders.
Combination To Expand Terra Tech's Operations
The merger with Golden Leaf will allow Terra Tech to substantially expand its U.S. operations.
The combined company will have 41 permits in Oregon, California and Nevada that cover the cultivation, manufacture, distribution and retail of cannabis, in addition to 21 permit applications in the U.S. that are pending, according to the announcement.
Terra Tech owns a number of subsidiaries — including Blüm, IVXX, Edible Garden and MediFarm — that operate in Nevada and California.
Blüm operates medical and recreational cannabis retail locations in the states, while IVXX produces cannabis-based products for medical dispensaries in California and adult-use stores in Nevada. Edible Garden provides sustainable-grown hydroponic produce that is sold in grocery stores across the country. MediFarm is engaged in the cultivation of medical and recreational cannabis in Nevada.
Golden Leaf is based in Canada, but also has operations in Oregon and Nevada. It is engaged in the cultivation and production of cannabis that is distributed either through its own Chalice Farms dispensaries or third-party locations.
Related Links:
Cannabis Is Now Legal In Canada: Industry Insiders Discusss What It Means For Stocks, International Market
6 Cannabis Companies Make Their Investment Pitch
See more from Benzinga
© 2018 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.